156 related articles for article (PubMed ID: 17916749)
21. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
[TBL] [Abstract][Full Text] [Related]
22. Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP).
Dasari VR; Velpula KK; Kaur K; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
PLoS One; 2010 Jul; 5(7):e11813. PubMed ID: 20676365
[TBL] [Abstract][Full Text] [Related]
23. Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.
Giaisi M; Köhler R; Fulda S; Krammer PH; Li-Weber M
Int J Cancer; 2012 Aug; 131(4):1003-8. PubMed ID: 21952919
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
25. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
26. Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance.
Fakler M; Loeder S; Vogler M; Schneider K; Jeremias I; Debatin KM; Fulda S
Blood; 2009 Feb; 113(8):1710-22. PubMed ID: 19036706
[TBL] [Abstract][Full Text] [Related]
27. Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction.
Dudich E; Semenkova L; Dudich I; Denesyuk A; Tatulov E; Korpela T
FEBS J; 2006 Aug; 273(16):3837-49. PubMed ID: 16869888
[TBL] [Abstract][Full Text] [Related]
28. ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up-regulation of the X-linked inhibitor of apoptosis.
Böhm B; Hess S; Krause K; Schirner A; Ewald W; Aigner T; Burkhardt H
Arthritis Rheum; 2010 May; 62(5):1372-82. PubMed ID: 20213810
[TBL] [Abstract][Full Text] [Related]
29. Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis.
Frenzel LP; Patz M; Pallasch CP; Brinker R; Claasen J; Schulz A; Hallek M; Kashkar H; Wendtner CM
Br J Haematol; 2011 Jan; 152(2):191-200. PubMed ID: 21091905
[TBL] [Abstract][Full Text] [Related]
30. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
[TBL] [Abstract][Full Text] [Related]
31. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
[TBL] [Abstract][Full Text] [Related]
32. Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas.
Hirpara JL; Loh T; Ng SB; Chng WJ; Pervaiz S
Oncotarget; 2016 Dec; 7(51):83964-83975. PubMed ID: 27863378
[TBL] [Abstract][Full Text] [Related]
33. Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells.
Shawgo ME; Shelton SN; Robertson JD
J Biol Chem; 2008 Dec; 283(51):35532-8. PubMed ID: 18927073
[TBL] [Abstract][Full Text] [Related]
34. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity.
Liston P; Fong WG; Kelly NL; Toji S; Miyazaki T; Conte D; Tamai K; Craig CG; McBurney MW; Korneluk RG
Nat Cell Biol; 2001 Feb; 3(2):128-33. PubMed ID: 11175744
[TBL] [Abstract][Full Text] [Related]
35. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
Tomicic MT; Christmann M; Kaina B
J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
[TBL] [Abstract][Full Text] [Related]
36. Caspase-9 cleavage, do you need it?
Twiddy D; Cain K
Biochem J; 2007 Jul; 405(1):e1-2. PubMed ID: 17555401
[TBL] [Abstract][Full Text] [Related]
37. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo.
Sun Y; Wu J; Aboukameel A; Banerjee S; Arnold AA; Chen J; Nikolovska-Coleska Z; Lin Y; Ling X; Yang D; Wang S; Al-Katib A; Mohammad RM
Cancer Biol Ther; 2008 Sep; 7(9):1418-26. PubMed ID: 18769131
[TBL] [Abstract][Full Text] [Related]
38. X-linked inhibitor of apoptosis protein levels and protein kinase C activity regulate the sensitivity of human endometrial carcinoma cells to tumor necrosis factor alpha-induced apoptosis.
Van Themsche C; Lafontaine L; Asselin E
Endocrinology; 2008 Aug; 149(8):3789-98. PubMed ID: 18467439
[TBL] [Abstract][Full Text] [Related]
39. Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival.
Uddin S; Hussain AR; Siraj AK; Manogaran PS; Al-Jomah NA; Moorji A; Atizado V; Al-Dayel F; Belgaumi A; El-Solh H; Ezzat A; Bavi P; Al-Kuraya KS
Blood; 2006 Dec; 108(13):4178-86. PubMed ID: 16946303
[TBL] [Abstract][Full Text] [Related]
40. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
